Economic Assessment of Delaying Insulin Treatment Through...

Economic Assessment of Delaying Insulin Treatment Through The Use of Newer Anti-Diabetic Agents, Dapagliflozin (Forxiga®) And Exenatide (Bydureon®), Both As Add-On To Metformin; A Cost-Effectiveness Analysis From A Uk Nhs Perspective

Charokopou, M., Vioix, H., Verheggen, B.G., Maddocks, D., Bratt, T., Franks, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.08.696
Date:
November, 2014
File:
PDF, 84 KB
english, 2014
Conversion to is in progress
Conversion to is failed